Therefore, we investigated whether CAV methylation is related to the prognosis of BC and found that the methylation levels in the CAV1 and CAV2 promoters were markedly higher than those in the corresponding para-cancerous tissues (Figures 4A–C). The gene discussed is CAV2; the disease is breast cancer.